FDI Policy, Clinical Trial Approvals, Compulsive licensing & the slowdown in the number of new product launches, regulatory challenges, the hostile economic environment in India, Drug Prices Control Order (DPCO) 2013 of lowering the prices of 348 essential drugs are some of the biggest challenges & worries for the leading Indian pharma companies seem to indicate that the lack of interest in staying in business leading to the wider concentration on reaching out to the doctors.
“There is widespread report of an unholy nexus between the doctors & the pharma companies in cementing commercial deals are distressing & is increasing rapidly in India despite MCI guidelines. Give & Take seem to be the order of the day resulting in the erosion of ethics in medical profession. It is widely believed that pharma companies & doctors are engaged in dubious commercial transactions as pharma companies feel that doctors have multiple options available to endorse the products in regular product basket unless the pharma company has something new to offer which compel the doctors to prescribe. This is the focal point at the Summit as we attempt to bring face to face with the drug companies & doctors in the single platform said” Satya Brahma
Pharmaleaders believe that though the entire scenario is not the same as doctors & pharma companies know that it is only the research driven products & efficacy in drugs are key but the large portion of the market need to increase the interaction on strong medical values & ethics in profession. Entering in its 6th Year, the much anticipated & awaited prestigious title is attempting to revisit the current state of medical profession & the pressure of building brands & most importantly, maintaining the sustainable growth record in an era where Government’s policy making machine making a difficult task to the thinking process & the strategies to retain market dominance. As Pharmaleaders march ahead to host the event, both domestic & international markets have been witnessing a change of approach. Indian pharmaceutical industry is globally ranked fourth in terms of volume, constituting 8% of total world’s production. Its value is estimated at $17 billion. India is now among the top five pharmaceutical emerging markets globally. The industry is expected to touch US$ 35.9 billion by 2016.
Pharmaleaders has padded some of the biggest names in the pharmaceutical & medical profession to debate on the wide ranging issues under the theme Incredible Pharmaleaders, Billion Dreams – Pushing India’s Growth on 27th December in Mumbai in India. Amongst the leaders who will address are Mr. Kewal Kanda, Promoter Director, Salus Lifecare Pvt Ltd on Decoding the success mantra of Indian Pharma Industry in an era of Govt regulations, Dr. Mukesh Batra, Founder Chairman, Dr. Batra’s Positive Health Clinic, on Challenges of Globalizing Homeopathic Medicines : A Dr. Batra’s Case Study, Dr. Shasank. R. Joshi ,Consulting Endocrinologist & Diabetologist on The Evolving Profile of the Indian Medical Practitioners : Doctors Expectations from the Pharmaceutical Companies – Beyond Gifts & Vacation Sponsorships, Mr. Deepak Naik, Managing Director, Health ‘N’ U Therapeutics Pvt. Ltd on Has the Pharmaceutical Companies failed to impress the doctors on medical education by adopting unethical means?, Dr. GSK Velu, Founder Chairman, Trivitron Group of Companies on Challenges & Oppourtunities of Indian Medical Device Industry, Dr. Shuba Dharmana, Cosmetic Dermatologist & Founder CEO, Le’jeune Medspa on The Changing Face of Indian Skincare Innovations, Prof. Dr. Nandkishore Shamrao Laud, Founder, Dr Laud Clinic on Cost effective Healthcare through citizens community participation. S. Krishnakumar of Future Steps will moderate the event. Dr. Kancherla Ravindranath, CMD, Global Hospitals Group, Dr. Kaushal Pandey, Cardiac Surgeon, Dr. Sudhir Vaishnav, Interventional Cardiologist, Dr. Deepak K Jhumani, Consultant in Sexual Health and Counsellor, Dr. Harish S. Bhende Orthopaedic Surgeon, Dr. Chytra v Anand, Founder & CEO & Chief Cosmetic Dermatologist, KOSMODERMA, Dr. Deepak Chaturvedi, Physician Endocrinologist & Diabetologist, will join in to a high voltage panel discussion on Ethics in Medical Profession. More than 250 Industry Leaders, Healthcare Experts, Pharma Academia, policy makers will be attending this historic summit.
6th Annual Pharmaceutical Leadership Summit 2013 will also felicitate the top doctors & pharma companies in 40 categories in a glittering award night.
To view the photograph, please click on the link given below:
Pharmaleaders Historic 6th Annual Pharma Summit 2013
Anish Khan, , +91 9819499475